bone marrow-derived mesenchymal stem cell therapy (NeoStem)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebone marrow-derived mesenchymal stem cell therapy (NeoStem)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Dermatogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsWounds and Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLisata Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLisata Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A